No Data
REITs Continue to Reduce NAV Discount Amid Increased Rate Cut Hopes
Deutsche Bank's Fresh Money List for 3Q
Truist Financial Maintains Sabra Health Care REIT Inc(SBRA.US) With Buy Rating, Raises Target Price to $16
Truist Financial analyst Michael Lewis maintains $Sabra Health Care REIT Inc(SBRA.US)$ with a buy rating, and adjusts the target price from $15 to $16.According to TipRanks data, the analyst has a suc
Sabra Healthcare REIT Is Maintained at Buy by Truist Securities
Sabra Healthcare REIT Is Maintained at Buy by Truist Securities
Express News | Sabra Health Care REIT Inc : Truist Securities Raises Target Price to $16 From $15
Truist Adjusts Price Target on Sabra Health Care REIT to $16 From $15, Maintains Buy Rating
Sabra Health Care REIT (SBRA) has an average outperform rating and a price target range of $14 to $21, according to analysts polled by Capital IQ.